← back to search

Jingjing Yu

Hebei Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Epigenetics and DNA Methylation, Cancer Cells and Metastasis, Cancer-related molecular mechanisms research, and Ferroptosis and cancer prognosis.
h-index
25
citations
2,260
works
135
NIH funding
primary concept
email

Recent publications

An endoplasmic reticulum-targeting NIR fluorescent probe for viscosity imaging in vitro and vivo
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy 2026cited by 0position: middledoi
Clostridium scindens promotes gallstone formation by inducing intrahepatic neutrophil extracellular traps through CXCL1 produced by colonic epithelial cells
Microbial Cell 2025cited by 4position: middledoi
Functional analysis of the woody oil crop Plukenetia volubilis L. LEC2 homolog PvoB3-69 in promoting regeneration
Plant Cell Reports 2025cited by 2position: firstdoi
Intra-articular injection of exosomes derived from different stem cells in animal models of osteoarthritis: a systematic review and meta- analysis
Journal of Orthopaedic Surgery and Research 2024cited by 18position: middledoi
Lipopolysaccharide in Bile Promotes the Neutrophil Extracellular Traps-Induced Gallstone Formation by Activating the Gallbladder Immune Barrier
ImmunoTargets and Therapy 2024cited by 14position: firstdoi
<i>Helicobacter pylori</i><scp>CagA</scp> Promotes the Formation of Gallstones by Increasing the Permeability of Gallbladder Epithelial Cells
Helicobacter 2024cited by 7position: firstdoi
RBCK1 overexpression is associated with immune cell infiltration and poor prognosis in hepatocellular carcinoma
Aging 2024cited by 5position: firstdoi
The use of MFAP2 for diagnosis, prognosis and immunotherapy of triple-negative breast cancer
American Journal of Translational Research 2024cited by 2position: firstdoi
E26 transformation-specific transcription variant 5 in development and cancer: modification, regulation and function
Journal of Biomedical Science 2023cited by 23position: middledoi
Fucosyltransferases Regulated by Fusobacterium Nucleatum and Act as Novel Biomarkers in Colon Adenocarcinoma
Journal of Inflammation Research 2023cited by 13position: middledoi
Association between the use of lipid‐lowering drugs and the risk of inflammatory bowel disease
European Journal of Clinical Investigation 2023cited by 5position: middledoi
Identification of flowering genes in Camellia perpetua by comparative transcriptome analysis
Functional & Integrative Genomics 2023cited by 5position: firstdoi
IL1RA mediated the effects of aspirin on COVID-19 severity: A Mendelian randomization study
Journal of Infection 2023cited by 4position: middledoi
Ring finger protein 12 activates <scp>AKT</scp> signalling to promote the progression of liver cancer by interacting with <scp>EGFR</scp>
Journal of Cellular and Molecular Medicine 2023cited by 3position: middledoi
The lncRNA TCONS_00021785/miR-21-5p/Trim33 axis regulates VMP1-mediated zymophagy, reduces the activation of trypsinogen, and promotes acinar cell recovery
Cell Death Discovery 2022cited by 12position: middledoi
Abnormal static and dynamic functional network connectivity in stable chronic obstructive pulmonary disease
Frontiers in Aging Neuroscience 2022cited by 10position: middledoi
Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles
Nature Communications 2021cited by 333position: middledoi
[A comparative study of breast cancer mass screening and opportunistic screening in Chinese women].
PubMed 2021cited by 3position: middledoi
MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner
Journal of Experimental & Clinical Cancer Research 2020cited by 52position: middledoi
Clinical characteristics of breast ductal carcinoma in situ with microinvasion: a narrative review
Journal of International Medical Research 2020cited by 24position: middledoi
Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway
Bosnian Journal of Basic Medical Sciences 2018cited by 56position: middledoi
Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B
Cancer Management and Research 2018cited by 20position: firstdoi
Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer
Cancer Biology & Therapy 2013cited by 28position: middledoi
Analysis of molecular classification and clinical characteristics in 36 patients with male breast cancer
肿瘤研究与临床 2013cited by 0position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Xuxu Liu · Harbin Medical University7 papers (2022–2025)Dongbo Xue · Harbin Medical University6 papers (2022–2025)Chenjun Hao · Harbin Medical University5 papers (2023–2025)Zhenyi Lv · Harbin Medical University4 papers (2022–2023)Bixiang Zhang · Wuhan Institute of Technology4 papers (2013–2023)Huifang Liang · Academy of Medical Sciences3 papers (2013–2023)Wenchao Yao · Nanjing University of Chinese Medicine3 papers (2023–2025)Yi Zheng · Guangzhou University of Chinese Medicine2 papers (2024–2024)Tianming Liu · University of Georgia2 papers (2024–2024)Jingyuan Wen · University of Auckland2 papers (2020–2023)Han Huang · Sun Yat-sen University2 papers (2023–2025)Zhao Huang · Shaoguan University2 papers (2020–2023)Jingyu Liao · China National Nuclear Corporation2 papers (2020–2023)Zeng‐Fu Xu · Guangxi University2 papers (2023–2025)Ziang Meng · Harbin Medical University2 papers (2023–2024)Zhanguo Zhang · Xuchang University1 papers (2013–2013)Haijun Li · Nanchang University1 papers (2022–2022)Ming‐Zhi Zhang · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2013–2013)Xin Li · Weifang People's Hospital1 papers (2021–2021)Long Zhang · Chongqing Medical University1 papers (2023–2023)